Synchronizing In Silico, In Vitro, and In Vivo Studies for the Successful Nose to Brain Delivery of an Anticancer Molecule

被引:22
作者
Abd-algaleel, Shaymaa A. [1 ]
Metwally, Abdelkader A. [2 ,3 ]
Abdel-Bar, Hend Mohamed [4 ]
Kassem, Dina H. [5 ]
Hathout, Rania M. [2 ]
机构
[1] Egyptian Drug Author, Dept Pharmaceut, Cairo 35521, Egypt
[2] Ain Shams Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo 11566, Egypt
[3] Kuwait Univ, Fac Pharm, Hlth Sci Ctr, Dept Pharmaceut, Safat 13110, Kuwait
[4] Univ Sadat City, Fac Pharm, Dept Pharmaceut, Menoufia 32897, Egypt
[5] Ain Shams Univ, Fac Pharm, Dept Biochem, Cairo 11566, Egypt
关键词
sesamol; solid lipid nanoparticles; polymeric nanoparticles; nose-to-brain delivery; glioma; SOLID LIPID NANOPARTICLES; DRUG-DELIVERY; PHYSICOCHEMICAL PROPERTIES; CHITOSAN NANOPARTICLES; SESAMOL; CYTOTOXICITY; PLGA; PENETRATION; FABRICATION; DYNAMICS;
D O I
10.1021/acs.molpharmaceut.1c00276
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Sesamol is a sesame seed constituent with reported activity against many types of cancer. In this work, two types of nanocarriers, solid lipid nanoparticles (SLNs) and polymeric nanoparticles (PNs), were exploited to improve sesamol efficiency against the glioma cancer cell line. The ability of the proposed systems for efficient brain targeting intranasally was also inspected. By the aid of two docking programs, the virtual loading pattern inside these nanocarriers was matched to the real experimental results. Interactions involved in sesamol-carrier binding were also assessed, followed by a discussion of how different scoring functions account for these interactions. The study is an extension of the computer-assisted drug formulation design series, which represents a promising initiative for an upcoming industrial innovation. The results proved the power of combined in silico tools in predicting members with the highest sesamol payload suitable for delivering a sufficient dose to the brain. Among nine carriers, glyceryl monostearate (GMS) and polycaprolactone (PCL) scored the highest sesamol payload practically and computationally. The EE % was 66.09 +/- 0.92 and 61.73 +/- 0.47 corresponding to a Delta G (binding energy) of -8.85 +/- 0.16 and -5.04 +/- 0.11, respectively. Dynamic light scattering evidenced the formation of 215.1 +/- 7.2 nm and 414.25 +/- 1.6 nm nanoparticles, respectively. Both formulations demonstrated an efficient cytotoxic effect and brain-targeting ability compared to the sesamol solution. This was evidenced by low IC50 (38.50 +/- 10.37 mu M and 27.81 +/- 2.76 mu M) and high drug targeting efficiency (7.64 +/- 1.89-fold and 13.72 +/- 4.1-fold) and direct transport percentages (86.12 +/- 3.89 and 92.198 +/- 2.09) for GMS-SLNs and PCL-PNs, respectively. The results also showed how different formulations, having different compositions and characteristics, could affect the cytotoxic and targeting ability.
引用
收藏
页码:3763 / 3776
页数:14
相关论文
共 79 条
  • [11] Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability
    Badran, Mohammad M.
    Alomrani, Abdullah H.
    Harisa, Gamaleldin I.
    Ashour, Abdelkader E.
    Kumar, Ashok
    Yassin, Alaa Eldeen
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2018, 106 : 1461 - 1468
  • [12] The influence of various amphiphilic excipients on the physicochemical properties of carbamazepine-loaded microparticles
    Barakat, Nahla S.
    Elanazi, Fars K.
    Almurshedi, Alanood S.
    [J]. JOURNAL OF MICROENCAPSULATION, 2009, 26 (03) : 251 - 262
  • [13] Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
    Bobo, Daniel
    Robinson, Kye J.
    Islam, Jiaul
    Thurecht, Kristofer J.
    Corrie, Simon R.
    [J]. PHARMACEUTICAL RESEARCH, 2016, 33 (10) : 2373 - 2387
  • [14] Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
    Bourganis, Vassilis
    Kammona, Olga
    Alexopoulos, Aleck
    Kiparissides, Costas
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 128 : 337 - 362
  • [15] Production of lipospheres as carriers for bioactive compounds
    Cortesi, R
    Esposito, E
    Luca, G
    Nastruzzi, C
    [J]. BIOMATERIALS, 2002, 23 (11) : 2283 - 2294
  • [16] Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?
    Costantino, Luca
    Boraschi, Diana
    [J]. DRUG DISCOVERY TODAY, 2012, 17 (7-8) : 367 - 378
  • [17] Das M.K., 2016, Chem Pharm Res, V8, P484
  • [18] Role of Molecular Dynamics and Related Methods in Drug Discovery
    De Vivo, Marco
    Masetti, Matteo
    Bottegoni, Giovanni
    Cavalli, Andrea
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (09) : 4035 - 4061
  • [19] Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles
    Di Gioia, Sante
    Trapani, Adriana
    Mandracchia, Delia
    De Giglio, Elvira
    Cometa, Stefania
    Mangini, Vincenzo
    Arnesano, Fabio
    Belgiovine, Giuliana
    Castellani, Stefano
    Pace, Lorenzo
    Lavecchia, Michele Angelo
    Trapani, Giuseppe
    Conese, Massimo
    Puglisi, Giovanni
    Cassano, Tommaso
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 94 : 180 - 193
  • [20] Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC)
    Doktorovova, Slavomira
    Araujo, Joana
    Garcia, Marisa L.
    Rakovsky, Erik
    Souto, Eliana B.
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2010, 75 (02) : 538 - 542